Stockholders Equity (Tables)

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Schedule of Assumption Used for Stock Options Activity

The following weighted average assumptions were used for grants during the following periods:

	Nine months ended September 30,
	2024		2023
Dividend Yield	0.00	%	n/a
Volatility	74.72	%	n/a
Risk-Free Interest Rate	4.17	%	n/a
Expected Life	3.50 years		n/a

Schedule of Stock Options Activity

A summary of stock option activity under the Company’s 2014 Plan for the nine months ended September 30, 2024 is as follows:

Stock Options	Number of Shares	Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at January 1, 2024	107,201	$	8.31	0.94	$	-
Granted	318,750	$	2.25	4.34	$	2,199,375
Exercised	(50,000)	$	8.72	-	$	25,000
Expired/Forfeited	(46,250)	$	2.25	4.67	$	112,238
Outstanding at September 30, 2024	329,701	$	3.24	3.56	$	1,948,716
Vested and Exercisable at September 30, 2024	57,201	$	7.95	0.32	$	68,466

Schedule of the Restricted Common Stock Activity

A summary of the restricted Common Stock activity under the 2014 Plan for nine months ended September 30, 2024 is as follows:

Restricted Stock Awards	Shares	Weighted Average Grant Date Fair Value per Share		Aggregate Fair Value
Balance at January 1, 2024	550,581	$	3.82	$	2,103,219
Granted	178,459	$	2.33	$	416,211
Vested	(446,044)	$	4.16	$	(1,855,543)
Forfeited	(2,000)	$	4.80	$	(9,600)
Balance at September 30, 2024	280,996	$	2.33	$	654,721